Posted by floatingbridge on May 17, 2011, at 10:05:25
In reply to Re: TDp Journal Article #2 + #3, posted by hyperfocus on May 15, 2011, at 17:56:25
I agree that we don't need more labels, especially alarming ones. I apologize about the thread title. It was an abbreviation of the journal titles.
What interests me most is that, whatever it may be called, some people's distress intensifies during their treatment with some selective agents. For some, this may be seperate from the noted
tendency of depressive illnesses to progress. It's a phenomena patients themselves could sense, but it can be difficult to explain to one's self, let alone a doctor. Especially a doctor who is locked into ssri's/snri's because they are 'the more advanced' (therefore superior) treatments. That doctors are more
widely advised is very important. Not all patients can, in their worst times, advocate for themselves.This could be very important to the treatment of the BPll and nos populations particularly.
I thank these researchers for studying a
commonly observed phenomena and attempting to further a dialogue within the psychiatric community. I think it takes a little hutzpah to publish a paper that offers no solutions and questions the safety of a deeply invested common practice. Yes, the name they coined does scare the pants off patients. I should have caught on sooner. My apologies for that.fb
* and whoever gazes at the stars will never again be quite alone...
c-ptsd & attendant health concerns
poster:floatingbridge
thread:985133
URL: http://www.dr-bob.org/babble/20110515/msgs/985531.html